116 software-verification-computer-science Postdoctoral positions at The Ohio State University
Sort by
Refine Your Search
-
reviewed on a rolling basis beginning mid-November. Required Qualifications: Candidates must hold a doctoral degree in economics, public policy and management, sociology, finance, public health, or computer
-
| Health and Rehab Sciences Department: Medicine | Health and Rehabilitation Sciences Position Summary We are seeking a highly motivated postdoctoral researcher to join an interdisciplinary team led by Dr
-
, and mass balance studies is highly desired. Required Education: Pharm.D.; Ph.D. in pharmaceutical sciences or equivalent program. Location: Parks Hall (0273) Position Type: Term (Fixed Term) Scheduled
-
in computational biology or related area. Demonstrated experience in computational research. Desired: Research interest in environmental microbiology and/or microbial ecology. Strong software skills
-
/Python/LabVIEW for data analysis and software experimental control. Also required are strong written and oral communications skills, interpersonal skills for collaborative science and mentorship, problem
-
); plans, designs, and executes experiments of considerable scope and complexity focusing on the mechanisms of heart failure and cardiomyopathies; conducts advanced cell biology research utilizing human
-
research projects. Complete required research and biosafety training. Required Qualifications: Ph.D. in Plant Pathology, Microbial Biology, Computational Biology, or a related field. Demonstrated experience
-
Sciences | Evolution Ecology and Organismal Biology-Interim The Postdoctoral Scholar will participate in a lab-based research project that evaluates the drivers of eye diversity and function under dim-light
-
& Therapeutics Department: Medicine | School Biomedical Sciences Molecular Medicine and Therapeutics Post Doctoral Scholar to pursue specialized research training, education, and experience under the guidance
-
activation, cytotoxicity, and persistence. Additional methods may involve CRISPR-based perturbations, viral vector engineering, and immune cell manufacturing workflows relevant to CAR-based therapies. In vivo